|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||48.45 - 48.77|
|52 Week Range||30.89 - 48.88|
|PE Ratio (TTM)||20.06|
|Dividend & Yield||0.95 (1.97%)|
|1y Target Est||N/A|
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is off more than 50% so far this year. This is one of the leading generic drug producers in the world. Unfortunately, U.S. courts changed the dynamic by allowing more generics competition sooner than TEVA counted on.
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Novo Nordisk A/S with the following peers – Pfizer Inc., Roche Holding Ltd Genusssch., Bristol-Myers Squibb Company, Eli Lilly and Company and Sanofi Sponsored ADR (PFE-US, RHHVF-US, BMY-US, LLY-US and SNY-US). Novo Nordisk A/S’s dividend yield is 1.69 percent and its dividend payout is 35.96 ... Read more (Read more...)
Rating Action: Moody's Affirms Seven Classes of WFCM 2016- NXS6. Global Credit Research- 15 Sep 2017. Approximately $574 Million of Structured Securities Affected.